Dexcom (DXCM) Total Non-Current Liabilities (2010 - 2026)

Dexcom (DXCM) has 17 years of Total Non-Current Liabilities data on file, last reported at $3.5 billion in Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $3.5 billion, down 18.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 billion (down 18.46% YoY), and the FY2025 annual result was $3.5 billion, down 18.36% from the prior year.
• Total Non-Current Liabilities grew to $3.5 billion in Q1 2026 per DXCM's latest filing, from $3.5 billion in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $4.6 billion in Q3 2025 and troughed at $2.8 billion in Q1 2022.
• A 5-year average of $3.8 billion and a median of $4.1 billion in 2024 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2023 and 2026: Total Non-Current Liabilities surged 60.28% in 2023, then fell 18.46% in 2026.
• A 5-year view of Total Non-Current Liabilities shows it stood at $3.1 billion in 2022, then rose by 29.98% to $4.1 billion in 2023, then grew by 4.02% to $4.2 billion in 2024, then dropped by 18.36% to $3.5 billion in 2025, then climbed by 2.25% to $3.5 billion in 2026.
• Business Quant data shows DXCM's Total Non-Current Liabilities at $3.5 billion in Q1 2026, $3.5 billion in Q4 2025, and $4.6 billion in Q3 2025.